Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones

Journal of Clinical Microbiology

Volumn 47, Issue 12, 2009, Pages 3985-3990

  Bravo, Lulette Tricia C ^a   Tuohy, Marion J ^a   Ang, Concepcion ^b   Destura, Raul V ^b   Mendoza, Myrna ^b   Procop, Gary W ^a   Gordon, Steven M ^a   Hall, Geraldine S ^a   Shrestha, Nabin K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; DNA EXTRACTION; GENE AMPLIFICATION; GYRA GENE; KATG GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PHENOTYPE; RIFAMPIN; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 71549120712     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01229-09     Document Type: Article

References (29)

1. Cavusoglu, C., A. Turhan, P. Akinci, and I. Soyler. 2006. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44:2338-2342.
2. Centers for Disease Control and Prevention. 2006. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 55:1176.
3. Conde, M. B., A. Efron, C. Loredo, G. R. De Souza, N. P. Graca, M. C. Cezar, M. Ram, M. A. Chaudhary, W. R. Bishai, A. L. Kritski, and R. E. Chaisson. 2009. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373:1183-1189.
4. Donald, P. R., and P. D. van Helden. 2009. The global burden of tuberculosis - combating drug resistance in difficult times. N. Engl. J. Med. 360:2393-2395.
5. Giannoni, F., E. Iona, F. Sementilli, L. Brunori, M. Pardini, G. B. Migliori, G. Orefici, and L. Fattorini. 2005. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:2928-2933.
6. Ginsburg, A. S., J. H. Grosset, and W. R. Bishai. 2003. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect. Dis. 3:432-442.
7. Goble, M., M. D. Iseman, L. A. Madsen, D. Waite, L. Ackerson, and C. R. Horsburgh, Jr. 1993. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med. 328:527-532.
8. Huang, T. S., C. M. Kunin, S. Shin-Jung Lee, Y. S. Chen, H. Z. Tu, and Y. C. Liu. 2005. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J. Antimicrob. Chemother. 56:1058-1062.
9. Jureen, P., L. Engstrand, S. Eriksson, A. Alderborn, M. Krabbe, and S. E. Hoffner. 2006. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J. Clin. Microbiol. 44:1925-1929.
10. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control, Atlanta, GA.
11. LaBombardi, V. J., and L. Cataldo-Caputzal. 1993. Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob. Agents Chemother. 37:1556-1557.
12. Marttila, H. J., J. Makinen, M. Marjamaki, and H. Soini. 2009. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur. J. Clin. Microbiol. Infect. Dis. 28:33-38.
13. Moadebi, S., C. K. Harder, M. J. Fitzgerald, K. R. Elwood, and F. Marra. 2007. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 67:2077-2099.
14. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
15. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard. NCCLS document M24-A. NCCLS/CLSI, Wayne, PA.
16. Palomino, J. C. 2006. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr. Opin. Pulm. Med. 12:172-178.
17. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
18. Riska, P. F., W. R. Jacobs, Jr., and D. Alland. 2000. Molecular determinants of drug resistance in tuberculosis. Int. J. Tuberc. Lung Dis. 4:S4-S10.
19. Ronaghi, M., M. Uhlén, and P. Nyrén. 1998. A sequencing method based on real-time pyrophosphate. Science 281:363, 365. (Pubitemid 28340773)
20. Rustomjee, R., C. Lienhardt, T. Kanyok, G. R. Davies, J. Levin, T. Mthiyane, C. Reddy, A. W. Sturm, F. A. Sirgel, J. Allen, D. J. Coleman, B. Fourie, D. A. Mitchison, and Gatifloxacin for TB (OFLOTUB) Study Team. 2008. A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 12:128-138.
21. Shi, R., J. Zhang, C. Li, Y. Kazumi, and I. Sugawara. 2006. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J. Clin. Microbiol. 44:4566-4568.
22. Shrestha, N. K. 2007. Rapid diagnostic testing for mycobacterial infections. Future Microbiol. 2:397-408. (Pubitemid 47365025)
23. Sreevatsan, S., X. Pan, K. E. Stockbauer, N. D. Connell, B. N. Kreiswirth, T. S. Whittam, and J. M. Musser. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94:9869-9874.
24. Taniguchi, H., H. Aramaki, Y. Nikaido, Y. Mizuguchi, M. Nakamura, T. Koga, and S. Yoshida. 1996. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:103-108.
25. Telzak, E. E., K. Sepkowitz, P. Alpert, S. Mannheimer, F. Medard, W. el-Sadr, S. Blum, A. Gagliardi, N. Salomon, and G. Turett. 1995. Multidrug-resistant tuberculosis in patients without HIV infection. N. Engl. J. Med. 333:907-911.
26. Tho, D. Q., D. T. Ha, P. M. Duy, N. T. Lan, D. V. Hoa, N. V. Chau, J. Farrar, and M. Caws. 2008. Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 12:1306-1312.
27. van Doorn, H. R., D. D. An, M. D. de Jong, N. T. Lan, D. V. Hoa, H. T. Quy, N. V. Chau, P. M. Duy, D. Q. Tho, N. T. Chinh, J. J. Farrar, and M. Caws. 2008. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int. J. Tuberc. Lung Dis. 12:736-742.
28. Wang, J. Y., L. N. Lee, H. C. Lai, S. K. Wang, I. S. Jan, C. J. Yu, P. R. Hsueh, and P. C. Yang. 2007. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J. Antimicrob. Chemother. 59:860-865.
29. Zhao, J. R., Y. J. Bai, Y. Wang, Q. H. Zhang, M. Luo, and X. J. Yan. 2005. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 9:328-332.